Vertex Pharmaceuticals Overview
Vertex Pharmaceuticals Target Price
Analysts' 12-month price predictions for VRTX.
Get informed when a big investor buys or sells
+ FollowShare Price
$441.74
Average Target Price
$549.38
24.4% upside
24.4% upside21 analysts in the last 4 months
High: $616 | Low: $436
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-27 | Truist FinancialDanielle Brill | $542 | 22.7% upside |  |
| 2026-05-06 | Barclays | $615 | 39.2% upside | |
| 2026-05-05 | Morgan Stanley | $616 | 39.4% upside | |
| 2026-05-05 | RBC CapitalBrian Abrahams | $543 | 22.9% upside | |
| 2026-05-05 | Bernstein | $572 | 29.5% upside | |
| 2026-05-05 | Canaccord Genuity | $436 |  1.3% downside | |
| 2026-04-30 | Canaccord Genuity | $437 | 1.1% downside | |
| 2026-04-10 | Morgan Stanley | $612 | 38.5% upside | |
| 2026-03-10 | Truist FinancialJoon Lee | $525 | 18.8% upside | |
| 2026-03-10 | JefferiesAkash Tewari | $580 | 31.3% upside | |
| 2026-03-02 | BMO CapitalEvan David Seigerman | $600 | 35.8% upside | |
| 2026-02-17 | Canaccord Genuity | $441 | 0.2% downside | |
| 2026-02-17 | BarclaysEliana Merle | $607 | 37.4% upside | |
| 2026-02-17 | H.C. WainwrightAndrew Fein | $591 | 33.8% upside | |
| 2026-02-13 | Morgan StanleyTerence Flynn | $570 | 29% upside | |
| 2026-02-13 | ScotiabankLouise Chen | $558 | 26.3% upside | |
| 2026-02-13 | RBC Capital | $541 | 22.5% upside | |
| 2026-02-13 | Bernstein | $577 | 30.6% upside | |
| 2026-02-13 | Cantor Fitzgerald | $590 | 33.6% upside | |
| 2026-02-13 | Stifel NicolausPaul Matteis | $466 | 5.5% upside | |
| 2026-02-13 | H.C. WainwrightAndrew Fein | $518 | 17.3% upside | |
| 2026-01-27 | Barclays | $606 | 37.2% upside | |
| 2026-01-26 | UBS | $545 | 23.4% upside | |
| 2026-01-23 | Evercore ISICory Kasimov | $530 | 20% upside | |
| 2026-01-22 | RBC CapitalBrian Abrahams | $546 | 23.6% upside | |
| 2026-01-06 | UBSMichael Yee | $535 | 21.1% upside | |
| 2025-12-29 | Leerink Partners | $525 | 18.8% upside | |
| 2025-12-05 | Morgan Stanley | $564 | 27.7% upside | |
| 2025-12-03 | Morgan StanleyTerence Flynn | $516 | 16.8% upside | |
| 2025-11-04 | RBC Capital | $415 | 6.1% downside | |
| 2025-11-04 | Cantor FitzgeraldCarter Gould | $485 | 9.8% upside | |
| 2025-11-04 | Stifel Nicolaus | $445 | 0.7% upside | |
| 2025-11-04 | BarclaysGena Wang | $414 | 6.3% downside | |
| 2025-10-10 | Morgan Stanley | $438 | 0.8% downside | |
| 2025-09-25 | Leerink Partners | $456 | 3.2% upside | |
| 2025-08-05 | Truist Financial | $490 | 10.9% upside | |
| 2025-08-05 | Stifel Nicolaus | $455 | 3% upside | |
| 2025-08-05 | UBSEliana Merle | $553 | 25.2% upside | |
| 2025-08-05 | BMO Capital | $530 | 20% upside | |
| 2025-08-05 | H.C. Wainwright | $478 | 8.2% upside | |
| 2025-08-05 | Morgan Stanley | $439 | 0.6% downside | |
| 2025-06-17 | RBC CapitalBrian Abrahams | $420 | 4.9% downside | |
| 2025-05-06 | ScotiabankGreg Harrison | $442 | 0.1% upside | |
| 2025-04-22 | Cantor Fitzgerald | $535 | 21.1% upside | |
| 2025-01-31 | BMO CapitalEvan Seigerman | $545 | 23.4% upside | |
| 2025-01-30 | Wells FargoMohit Bansal | $460 | 4.1% upside | |
| 2025-01-10 | Morgan StanleyTerence Flynn | $456 | 3.2% upside | |
| 2024-12-19 | RBC CapitalBrian Abrahams | $400 | 9.4% downside | |
| 2024-12-09 | JefferiesMichael Yee | $550 | 24.5% upside | |
| 2024-11-05 | OppenheimerHartaj Singh | $540 | 22.2% upside | |